Biosensors are changing how we monitor health, but rapid innovation raises tough questions around privacy, regulation, and access. This article breaks down the key issues shaping their future.

Orthocell receives US FDA 510(k) approval for Remplir, its flagship nerve repair product and can now start commercial ...

Lifesciences industry sees significant shifts with digital transformation & increased M&As: Chandra Ambadipudi: Nandita Vijayasimha, Bengaluru Friday, April 4, 2025, 08:00 Hrs [IS ...